Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Ryall Brown | M | 75 |
Healx Ltd.
 Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | 10 years |
| Jonathan Milner | M | 59 |
Healx Ltd.
Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | - |
| Suranga Chandratillake | M | 47 |
Healx Ltd.
Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | 6 years |
| Shaun Francis Grady | M | 63 |
Healx Ltd.
Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | - |
| Irina Haivas | F | - |
Healx Ltd.
Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | 5 years |
| Eugenia Wachters | F | - |
Healx Ltd.
Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | 4 years |
| Elia Stupka | M | - |
Healx Ltd.
Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chiara Sommer | F | - |
Healx Ltd.
Healx Ltd. BiotechnologyHealth Technology Healx Ltd. engages in the development of a platform that enables treatment predictions for rare diseases. It offers HealNet, an artificial intelligence platform for rare diseases. Its solutions include orphan disease strategy, indication expansion, combination therapies, and shelved assets. The company was founded by Tim Guilliams and David Ryall Brownn and is headquartered in Cambridge, the United Kingdom. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 8 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tim Guilliams
- Personal Network
